KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nu Skin Enterprises (NUS) Shares Outstanding (Diluted Average) (2016 - 2025)

Nu Skin Enterprises (NUS) has disclosed Shares Outstanding (Diluted Average) for 17 consecutive years, with $50.3 million as the latest value for Q3 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 1.16% to $50.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $50.3 million through Sep 2025, up 1.16% year-over-year, with the annual reading at $59.1 million for FY2015, 3.01% down from the prior year.
  • Shares Outstanding (Diluted Average) hit $50.3 million in Q3 2025 for Nu Skin Enterprises, up from $49.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $52.2 million in Q1 2021 to a low of $49.5 million in Q2 2025.
  • Historically, Shares Outstanding (Diluted Average) has averaged $50.4 million across 5 years, with a median of $50.2 million in 2022.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): decreased 5.32% in 2021 and later rose 1.59% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $51.3 million in 2021, then decreased by 2.07% to $50.2 million in 2022, then decreased by 0.34% to $50.0 million in 2023, then fell by 0.59% to $49.7 million in 2024, then rose by 1.16% to $50.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for NUS at $50.3 million in Q3 2025, $49.5 million in Q2 2025, and $50.3 million in Q1 2025.